ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,223, issued on May 13, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Stevenage, Great Britain) and Fimbrion Therapeutics Inc. (Saint Louis, Mich.).
"Compounds" was invented by Michael Joseph Bishop (Collegeville, Pa.), James Walter Janetka (Saint Louis, Mo.), Laurel Kathryn McGrane (Saint Louis, Mo.), Eugene Lee Stewart (Collegeville, Pa.) and Katherine Louisa Widdowson (Collegeville, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are new C-mannoside compounds and compositions and their application as pharmaceuticals for the treatment of human disease. Methods of inhibition of FimH activity in human sub...